Integrated Diagnostics Holdings plc (IDGXF)
USD 0.32
(13.78%)
USD 0.32
(13.78%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 4.12 Billion EGP | 14.35% |
| 2022 | 3.6 Billion EGP | -31.0% |
| 2021 | 5.22 Billion EGP | 96.69% |
| 2020 | 2.65 Billion EGP | 19.3% |
| 2019 | 2.22 Billion EGP | 15.88% |
| 2018 | 1.92 Billion EGP | 26.89% |
| 2017 | 1.51 Billion EGP | 29.36% |
| 2016 | 1.17 Billion EGP | 15.35% |
| 2015 | 1.01 Billion EGP | 17.97% |
| 2014 | 860.23 Million EGP | 28.09% |
| 2013 | 671.58 Million EGP | 4.67% |
| 2012 | 641.59 Million EGP | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q1 | 1.17 Billion EGP | 9.52% |
| 2024 Q2 | 1.32 Billion EGP | 13.39% |
| 2023 Q3 | 1.18 Billion EGP | 23.53% |
| 2023 Q4 | 1.06 Billion EGP | -9.55% |
| 2023 FY | 4.12 Billion EGP | 14.35% |
| 2023 Q1 | 915.29 Million EGP | 13.74% |
| 2023 Q2 | 956.65 Million EGP | 4.52% |
| 2022 Q2 | 773.58 Million EGP | -34.47% |
| 2022 Q1 | 1.18 Billion EGP | -19.04% |
| 2022 Q4 | 804.73 Million EGP | -4.91% |
| 2022 Q3 | 846.25 Million EGP | 9.39% |
| 2022 FY | 3.6 Billion EGP | -31.0% |
| 2021 Q3 | 1.47 Billion EGP | 26.62% |
| 2021 Q4 | 1.45 Billion EGP | -1.04% |
| 2021 FY | 5.22 Billion EGP | 96.69% |
| 2021 Q2 | 1.16 Billion EGP | 3.02% |
| 2021 Q1 | 1.12 Billion EGP | 14.52% |
| 2020 Q4 | 986.28 Million EGP | 36.93% |
| 2020 FY | 2.65 Billion EGP | 19.3% |
| 2020 Q3 | 720.29 Million EGP | 60.09% |
| 2020 Q2 | 449.93 Million EGP | -9.97% |
| 2020 Q1 | 499.75 Million EGP | -13.46% |
| 2019 Q2 | 514.96 Million EGP | -5.68% |
| 2019 Q1 | 546 Million EGP | 0.28% |
| 2019 FY | 2.22 Billion EGP | 15.88% |
| 2019 Q4 | 577.49 Million EGP | -1.79% |
| 2019 Q3 | 588.03 Million EGP | 14.19% |
| 2018 FY | 1.92 Billion EGP | 26.89% |
| 2018 Q2 | 432.92 Million EGP | 0.0% |
| 2018 Q4 | 544.45 Million EGP | 6.52% |
| 2018 Q1 | 432.92 Million EGP | 4.76% |
| 2018 Q3 | 511.14 Million EGP | 18.07% |
| 2017 Q2 | 342.56 Million EGP | 0.0% |
| 2017 FY | 1.51 Billion EGP | 29.36% |
| 2017 Q1 | 342.56 Million EGP | 5.79% |
| 2017 Q3 | 415.86 Million EGP | 21.4% |
| 2017 Q4 | 413.25 Million EGP | -0.63% |
| 2016 Q2 | 276.27 Million EGP | 0.0% |
| 2016 FY | 1.17 Billion EGP | 15.35% |
| 2016 Q4 | 323.82 Million EGP | 10.05% |
| 2016 Q3 | 294.26 Million EGP | 6.51% |
| 2016 Q1 | 276.27 Million EGP | 2.5% |
| 2015 Q2 | 246.61 Million EGP | 0.0% |
| 2015 Q1 | 246.61 Million EGP | 4.86% |
| 2015 FY | 1.01 Billion EGP | 17.97% |
| 2015 Q4 | 269.54 Million EGP | 6.93% |
| 2015 Q3 | 252.06 Million EGP | 2.21% |
| 2014 Q4 | 235.18 Million EGP | 9.36% |
| 2014 Q3 | 215.05 Million EGP | 3.19% |
| 2014 Q2 | 208.41 Million EGP | -0.0% |
| 2014 Q1 | 208.41 Million EGP | 14.75% |
| 2014 FY | 860.23 Million EGP | 28.09% |
| 2013 FY | 671.58 Million EGP | 4.67% |
| 2013 Q2 | 167.89 Million EGP | 0.0% |
| 2013 Q3 | 167.89 Million EGP | 0.0% |
| 2013 Q4 | 181.61 Million EGP | 8.17% |
| 2013 Q1 | 167.89 Million EGP | 0.0% |
| 2012 FY | 641.59 Million EGP | 0.0% |
| 2012 Q4 | 167.89 Million EGP | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| American Bio Medica Corporation | 913 Thousand USD | -451434.064% |
| Arrayit Corporation | 4.37 Million USD | -94079.197% |
| Atlantic International Corp. | - USD | -Infinity% |
| Biocept, Inc. | 25.85 Million USD | -15842.865% |
| Bioqual, Inc. | 58.59 Million USD | -6936.08% |
| CardioGenics Holdings Inc | - USD | -Infinity% |
| DermTech, Inc. | 15.29 Million USD | -26851.53% |
| Global WholeHealth Partners Corporation | - USD | -Infinity% |
| Hangzhou Tigermed Consulting Co., Ltd. | 7.38 Billion USD | 44.17% |
| HTG Molecular Diagnostics, Inc. | 6.36 Million USD | -64655.946% |
| iMD Companies, Inc. | - USD | -Infinity% |
| IDenta Corp. | 1.05 Million USD | -391925.98% |
| Interpace Biosciences, Inc. | 40.21 Million USD | -10151.42% |
| Integrative Health Technologies, Inc. | 447.49 Thousand USD | -921132.45% |
| InVitro International | 792.62 Thousand USD | -520006.027% |
| Lumos Diagnostics Holdings Limited | 11.13 Million USD | -36936.259% |
| Many Bright Ideas Technologies Inc. | - USD | -Infinity% |
| Medical Imaging Corp. | 7.22 Million USD | -56965.02% |
| NovelStem International Corp. | 12 Thousand USD | -34354116.667% |
| Optigenex Inc. | 465.97 Thousand USD | -884614.896% |
| PharmChem, Inc. | 6.01 Million USD | -68466.695% |
| Proteome Sciences plc | 6.4 Million USD | -64307.675% |
| Response Genetics, Inc | 18.04 Million USD | -22752.029% |
| Rennova Health, Inc. | 13.03 Million USD | -31523.593% |
| RushNet, Inc. | 1.78 Million USD | -230480.688% |
| ScreenPro Security Inc. | 1.91 Million USD | -215275.348% |
| Stella Diagnostics Inc. | - USD | -Infinity% |
| StageZero Life Sciences Ltd. | 3.79 Million USD | -108527.759% |
| Todos Medical Ltd. | 7.69 Million USD | -53473.827% |